epocrates logo
epocrates logo
epocrates logo
  • 0

Herbs & Supplements

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Formulary
No Formulary Selected

close

 

Select a medication above to begin.

feuille de vigne rouge AS 195

grape (Vitis spp.)

Sections:

  • Entire Monograph
  • Reported Uses
  • Reported Doses
  • Cautions
  • Drug Interactions
  • Adverse Reactions
  • Synonyms
  • Other Info
  • Add to Interaction Check

Reported Uses

  • NOTE: see Herb & Supplement Effectiveness Rating Definitions table
  • ADHD [Insufficient Evidence]
  • age-related macular degeneration [Insufficient Evidence]
  • aging skin [Insufficient Evidence]
  • allergic rhinitis [Possibly Ineffective]
  • aphthous ulcer (canker sores) [Insufficient Evidence]
  • atherosclerosis [Insufficient Evidence]
  • athletic performance [Insufficient Evidence]
  • atopic dermatitis (eczema) [Insufficient Evidence]
  • cardiovascular disease [Insufficient Evidence]
  • chronic venous insufficiency [Possibly Effective]
  • cognitive function [Insufficient Evidence]
  • cognitive impairment [Insufficient Evidence]
  • colorectal CA [Insufficient Evidence]
  • constipation [Insufficient Evidence]
  • dental caries [Insufficient Evidence]
  • diabetes mellitus [Insufficient Evidence]
  • diabetic retinopathy [Insufficient Evidence]
  • erectile dysfunction [Insufficient Evidence]
  • hemorrhoids [Insufficient Evidence]
  • HTN [Insufficient Evidence]
  • hypercholesterolemia [Insufficient Evidence]
  • lower urinary tract symptoms [Possibly Ineffective]
  • mastalgia [Possibly Ineffective]
  • melasma [Insufficient Evidence]
  • menopausal symptoms [Insufficient Evidence]
  • metabolic syndrome [Insufficient Evidence]
  • minor external bleeding [Insufficient Evidence]
  • muscle soreness [Insufficient Evidence]
  • nausea/vomiting, chemo-related [Possibly Ineffective]
  • night vision [Insufficient Evidence]
  • metabolic dysfunction-associated steatotic liver disease [Insufficient Evidence]
  • obesity [Possibly Ineffective]
  • ocular stress [Insufficient Evidence]
  • premenstrual syndrome [Insufficient Evidence]
  • wound healing [Insufficient Evidence]

Copyright © 2026. All Rights Reserved. Republication or redistribution, including by framing or similar means, is prohibited without the prior written consent of copyright holder.

Select a medication above to begin.

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information